Medical Advocates
Pegylated Interferon alfa-2b (PEG-INTRON)
 
Disease Index

New and Noteworthy
HBV
HCV
HIV/HCV
HCV/HBV
HDV
Other Diseases
US ADAP

  
Peg Inf alpha 2b Main Page Main New/Newsworthy  Home Page
Last Update:  February 08, 2016
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
February 2016
 
HCV/HBV Coinfection
 
      Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-alpha2b plus ribavirin treatment in a patient with hepatitis B and C coinfection.
Rautou PE, Asselah T, Saadoun D, et al
Eur J Gastroenterol Hepatol. 2006 Sep;18(9):1019-22.
 Abstract
Hepatitis Delta (HDV) Infection/Disease
 

      Journal Papers, Abstracts, and Commentaries
 
  Treatment of chronic hepatitis delta with pegylated interferon-alpha2b.
 Erhardt A, Gerlich W, Starke C, et al
Liver Int. 2006 Sep;26(7):805-10.
 Abstract
 
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.
 Niro GA, Ciancio A, Gaeta GB, Smedile A, et al  
Hepatology. 2006 Sep;44(3):536-9.
Abstract
 
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up.
 Castelnau C, Le Gal F, Ripault MP, Gordien E, et al
 Hepatology. 2006 Sep;44(3):728-35.
Abstract
Other Disease
 
Human Papillomavirus

      Journal Papers, Abstracts, and Commentaries
 
  FULL TEXT ARTICLE
 Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin.
 Pavan MH, Velho PE, Vigani AG, et al 
Braz J Infect Dis. 2007 Jun;11(3):383-4.
 Paper
 
Lymphangiomatosis
 
      Journal Papers, Abstracts, and Commentaries
 
  Clinical improvement of diffuse lymphangiomatosis with pegylated interferon alfa-2b therapy: case report and review of the literature.
Ozeki M, Funato M, Kanda K, et al
Pediatr Hematol Oncol. 2007 Oct-Nov;24(7):513-24.
 Abstract
 
Melanoma
 
      Journal Papers, Abstracts, and Commentaries
 
  Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991).
Eggermont AM, Bouwhuis MG, Kruit WH, et al
Cancer Chemother Pharmacol. 2010 Mar;65(4):671-7.
Abstract
 
Polycythemia Vera

      Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia.
 Samuelsson J, Mutschler M, Birgegard G,  
Haematologica. 2006 Sep;91(9):1281-2
 Paper
 
Thrombocytopenia

      Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia.
 Samuelsson J, Mutschler M, Birgegard G,  
Haematologica. 2006 Sep;91(9):1281-2
 Paper
US AIDS Drug Assistance Program
 
News
 
  FULL-TEXT PDF NEWS RELEASE
AIDS Drug Assistance Programs (ADAPs) to Benefit from First National Program Providing ADAP Patients with Hepatitis C Medicine
 NASTAD  
February 18, 2005
News Release

PegInf Main Page Main New/Newsworthy  Home Page

Peginterferon alfa-2b Main Page